Sonia Rao - Peptides Today News and Research

Neuropeptide Y: Charting the Clinical Viability of an Endogenous Anticonvulsant in Epilepsy Research

Sonia Rao February 2, 2026 No Comments

Neuropeptide Y epilepsy research is gaining momentum as scientists search for better treatments for drug resistant seizures. Epilepsy remains one of the most challenging neurological disorders worldwide. Around 50 million…

GsMTx4-Derived Peptides: A Realistic Assessment of TRPV4-Targeted Non-Opioid Analgesia in Preclinical Development

Sonia Rao February 2, 2026 No Comments

The search for safer and more effective pain treatments has pushed modern pharmacology to explore non-opioid mechanisms with greater urgency than ever before. Traditional therapies often fall short, while opioids,…

Advancing the Front Line: Assessing Serum-Stable Peptide Prodrugs for Multidrug-Resistant Acinetobacter baumannii

Sonia Rao January 30, 2026 No Comments

Acinetobacter baumannii is one of the most dangerous multidrug-resistant pathogens facing modern healthcare systems today. This opportunistic bacterium thrives in hospital environments and disproportionately affects critically ill patients, especially those…

ALV-100: Assessing the Clinical Trajectory of Alveus Therapeutics’ Next-Generation Bifunctional Peptide for Obesity and Metabolic Disease

Sonia Rao January 29, 2026 No Comments

ALV-100 enters development at a time when obesity and metabolic disease have become some of the most pressing global health challenges. Rates of obesity continue to rise, while related conditions…

Peptide-Based Antivirals: Assessing the Clinical Viability of a Novel SARS-CoV-2 Spike Inhibitor

Sonia Rao January 28, 2026 No Comments

The global search for effective peptide-based antivirals has intensified as SARS-CoV-2 continues to evolve. New variants keep testing the limits of vaccines and small-molecule drugs. Honestly, it feels like a…

Navigating the Aggregation Labyrinth: Ellen Brunzell’s Strategic Insights into Peptide Formulation and Clinical Viability

Sonia Rao January 27, 2026 No Comments

Peptide aggregation in drug development is one of the most persistent and costly challenges facing modern pharmaceutical research. As peptide therapeutics continue to grow as a drug class, with the…

HLA-B Leader Peptide Variants and CMV Serostatus: A Critical Nexus for Early T Cell-Mediated Rejection in Kidney Transplantation

Sonia Rao January 27, 2026 No Comments

The HLA-B leader peptide is emerging as a critical immunogenetic factor in kidney transplantation, particularly in the context of early T cell-mediated rejection. Despite major advances in immunosuppressive therapy, early…

SA-XV Peptide: A Comprehensive Clinical and Regulatory Assessment for Fungal Keratitis

Sonia Rao January 26, 2026 No Comments

The emergence of SA-XV, a 15-residue peptide derived from the host-defense peptide S100A12, represents a critical development in addressing fungal keratitis—a devastating, sight-threatening corneal infection with significant global health implications.…

Author: Sonia Rao

Sign up to Get Latest Updates